Kyntra Bio, Inc. - PE Ratio

The PE Ratio as of September 2026 (TTM) for Kyntra Bio, Inc. (KYNB) is -0.58

According to Kyntra Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.58. This represents a change of -580.72% compared to the average of 0.12 of the last 4 quarters.

Kyntra Bio, Inc. (KYNB) Historical PE Ratio (quarterly & annually)

How has KYNB PE Ratio performed in the past?

The mean historical PE Ratio of Kyntra Bio, Inc. over the last ten years is -427.25. The current -0.58 PE Ratio has changed -86.42% with respect to the historical average. Over the past ten years (40 quarters), KYNB's PE Ratio was at its highest in in the December 2018 quarter at 1.16K. The PE Ratio was at its lowest in in the June 2018 quarter at -1397.32.

Kyntra Bio, Inc. (KYNB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kyntra Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kyntra Bio, Inc. (KYNB) Average PE Ratio

How has KYNB PE Ratio performed in the past?

The current PE Ratio of Kyntra Bio, Inc. (KYNB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Kyntra Bio, Inc. (KYNB) PE Ratio vs. Peers

How is KYNB’s PE Ratio compared to its peers?

Kyntra Bio, Inc.’s PE Ratio is greater than Kezar Life Sciences, Inc. (-1.18), less than Tempest Therapeutics, Inc. (-0.20), greater than Aligos Therapeutics, Inc. (-0.71), greater than OnKure Therapeutics, Inc. (-0.85), greater than Mersana Therapeutics, Inc. (-2.59), greater than X4 Pharmaceuticals, Inc. (-2.92), greater than PDS Biotechnology Corporation (-1.32), less than Celularity Inc. (-0.34), greater than Xilio Therapeutics, Inc. (-6.07), less than Actinium Pharmaceuticals, Inc. (3.31),

Build a custom stock screener for Kyntra Bio, Inc. (KYNB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kyntra Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kyntra Bio, Inc. (KYNB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kyntra Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.